The Patent Finder

Nalpropion Pharmaceuticals LLC

Also on record
Records under this name other than the patents Nalpropion Pharmaceuticals LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 24 patents it holds.

Showing 1 to 7 of 7 · Back to Nalpropion Pharmaceuticals LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,375,111Compositions for Affecting Weight Loss
Term ended
Term ended Mar 26, 2025 · High confidence
Term endedTerm ended Mar 26, 2025High confidence
US 7,462,626Compositions for Affecting Weight Loss
Term ended
Term ended Jul 20, 2024 · High confidence
Term endedTerm ended Jul 20, 2024High confidence
US 8,815,889Compositions and methods for increasing insulin sensitivity
Term ended
Term ended Jul 20, 2024 · High confidence
Term endedTerm ended Jul 20, 2024High confidence
US 9,457,005Compositions and Methods for Increasing Insulin Sensitivity
Term ended
Term ended Jul 20, 2024 · High confidence
Term endedTerm ended Jul 20, 2024High confidence
US 10,238,647Compositions for Affecting Weight Loss
Term ended
Term ended Apr 21, 2024 · Medium confidence
Term endedTerm ended Apr 21, 2024Medium confidence
US 11,139,056Methods of Treating Overweight and Obesity
Term ended
Term ended Apr 21, 2024 · High confidence
Term endedTerm ended Apr 21, 2024High confidence
US 11,278,544Compositions For Affecting Weight Loss
Term ended
Term ended Apr 21, 2024 · Medium confidence
Term endedTerm ended Apr 21, 2024Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited